The positive correlation of high SAD values and high BCR-ABL1 gene expression levels (see Fig. 3b) suggests that the SAD value derived from granulocyte-depleted MNC fractions may positively correlate with disease status/progression in CML. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.